About This Deal

ABBOTT LABORATORIES acquired Cardiovascular Systems, Inc. (CSI) for $851 million ($20.00 per common share), a transaction completed in April 2023, structured as All-cash.

Cardiovascular Systems, Inc. (CSI) operates in Medical devices — vascular, is based in St. Paul, Minnesota, USA. Cardiovascular Systems, Inc. (CSI) makes an atherectomy system used in treating peripheral and coronary artery disease, adding complementary technologies to Abbott's portfolio of vascular device offerings.

CSI's atherectomy system adds complementary technologies to Abbott's portfolio of vascular device offerings.

Complementary atherectomy technology for Abbott Vascular. Integrated into Abbott's Medical Devices (Vascular) business

Deal Terms

Acquirer
ABBOTT LABORATORIES
Target
Cardiovascular Systems, Inc. (CSI)
Value
$851 million ($20.00 per common share)
Date
April 2023
Type
Full acquisition
Status
Ready

Transaction Details

Target HQ
St. Paul, Minnesota, USA
Segment
Medical devices — vascular
Structure
All-cash
Closed
April 27, 2023

In Their Words

On April 27, 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI). CSI's atherectomy system, which is used in treating peripheral and coronary artery disease, adds complementary technologies to Abbott's portfolio of vascular device offerings.Abbott FY2023 10-K, Item 1 Business

Advisors

Advisory firms were not disclosed for this transaction.

Related Deals & Entities

Sources: Press release ↗

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.